Trumenba: latest news - GoINPHARMA
Thursday, 13 December 2018 - 9:54


OK in Europe to Pfizer’s Trumenba, meningococcal B vaccine

Pfizer announced today that its vaccine Trumenba was granted approval by the European Commission for the prevention of the infection and the disease caused by Neisseria meningitidis serogroup B (MenB) in individuals 10 years of age and older. Specifically, adolescents…

CHMP, positive opinion on Pfizer’s Trumenba

EMA CHMP adopted a positive opinion to grant a marketing authorization for Pfizer’s Trumenba. The product is intended for prophylaxis against group B meningococcal infections. It will be available as a suspension for injection. The active substances of the product…